These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36207131)

  • 1. COVID-19 vaccine triggered autoimmune hepatitis: case report.
    Mathew M; John SB; Sebastian J; Ravi MD
    Eur J Hosp Pharm; 2023 Sep; 30(5):e27. PubMed ID: 36207131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases.
    Wang M; Qi J; Liu Y
    Drug Discov Ther; 2023 Jul; 17(3):177-182. PubMed ID: 37331808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
    Ueno M; Takabatake H; Itakura J; Fujita R; Kayahara T; Morimoto Y; Notohara K; Mizuno M
    Clin J Gastroenterol; 2023 Aug; 16(4):554-558. PubMed ID: 37029249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto-immune hepatitis following COVID vaccination.
    Rela M; Jothimani D; Vij M; Rajakumar A; Rammohan A
    J Autoimmun; 2021 Sep; 123():102688. PubMed ID: 34225251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hepatitis with history of HCV treatment triggered by COVID-19 vaccination: case report and literature review.
    Hasegawa N; Matsuoka R; Ishikawa N; Endo M; Terasaki M; Seo E; Tsuchiya K
    Clin J Gastroenterol; 2022 Aug; 15(4):791-795. PubMed ID: 35716255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature.
    Chow KW; Pham NV; Ibrahim BM; Hong K; Saab S
    Dig Dis Sci; 2022 Sep; 67(9):4574-4580. PubMed ID: 35486203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine and autoimmune hepatitis.
    Sookaromdee P; Wiwanitkit V
    Rev Esp Enferm Dig; 2022 Oct; 114(10):631. PubMed ID: 35469403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis after COVID-19 vaccination.
    Zheng H; Zhang T; Xu Y; Lu X; Sang X
    Front Immunol; 2022; 13():1035073. PubMed ID: 36505482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.
    Uzun S; Zinner CP; Beenen AC; Alborelli I; Bartoszek EM; Yeung J; Calgua B; Reinscheid M; Bronsert P; Stalder AK; Haslbauer JD; Vosbeck J; Mazzucchelli L; Hoffmann T; Terracciano LM; Hutter G; Manz M; Panne I; Boettler T; Hofmann M; Bengsch B; Heim MH; Bernsmeier C; Jiang S; Tzankov A; Terziroli Beretta-Piccoli B; Matter MS
    J Hepatol; 2023 Sep; 79(3):666-676. PubMed ID: 37290592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review.
    van Gemeren MA; van Wijngaarden P; Doukas M; de Man RA
    Scand J Gastroenterol; 2017 Jan; 52(1):18-22. PubMed ID: 27565372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    Avci E; Abasiyanik F
    J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?
    López Romero-Salazar F; Veras Lista M; Gómez-Domínguez E; Ibarrola-Andrés C; Muñoz Gómez R; Fernández Vázquez I
    Rev Esp Enferm Dig; 2022 Sep; 114(9):567-568. PubMed ID: 35373571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Vuille-Lessard É; Montani M; Bosch J; Semmo N
    J Autoimmun; 2021 Sep; 123():102710. PubMed ID: 34332438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.
    Lasagna A; Lenti MV; Cassaniti I; Sacchi P
    Immunotherapy; 2022 Aug; 14(12):915-925. PubMed ID: 35694999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine triggered autoimmune hepatitis: case report.
    Mathew M; John SB; Sebastian J; Ravi MD
    Eur J Hosp Pharm; 2023 Dec; 31(1):82-83. PubMed ID: 37591684
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune hepatitis following mRNA COVID-19 vaccine.
    Zaiem A; Ferchichi K; Lakhoua G; Kaabi W; Aouinti I; Rebii Debbiche S; Kastalli S; Kallel L; Charfi O; El Aidli S
    Therapie; 2023; 78(6):760-761. PubMed ID: 37704459
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Kochhar S; Assis DN; Mack C; Izurieta HS; Muratori L; Munoz A; Nordenberg D; Gidudu JF; Blau EF; Vierling JM
    Vaccine; 2024 Mar; 42(7):1812-1825. PubMed ID: 38368225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.